Diclofenac Epolamine
Brand name: Licart
Rank #255 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$50.5M
Total Cost
72,299
Total Claims
$50.5M
Total Cost
652
Prescribers
$698
Cost per Claim
16,808
Beneficiaries
82,880
30-Day Fills
$77K
Avg Cost/Provider
111
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$50.5M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $50.5M total
Top Prescribers of Diclofenac Epolamine
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Ding Yang | Podiatry | Staten Island, NY | 6,649 | $5.9M |
| 2 | Kwangsu Kim | Podiatry | Tuckahoe, NY | 4,286 | $2.7M |
| 3 | Jiho Choi | Family Practice | Annandale, VA | 1,987 | $1.6M |
| 4 | Xiaoqin Yin | Family Practice | Flushing, NY | 1,873 | $1.2M |
| 5 | Fufu He | Family Practice | Brooklyn, NY | 1,155 | $1.0M |
| 6 | Chang Lee | Internal Medicine | Flushing, NY | 1,570 | $950K |
| 7 | Anthony Jung | Internal Medicine | Flushing, NY | 1,265 | $908K |
| 8 | Simon Li | Family Practice | Brooklyn, NY | 1,194 | $868K |
| 9 | Yun Hee Chung | Internal Medicine | Flushing, NY | 891 | $732K |
| 10 | Xiangsheng Zheng | Internal Medicine | Birmingham, AL | 1,073 | $706K |
| 11 | Yuan Zhang | Nurse Practitioner | New York, NY | 870 | $674K |
| 12 | Sea Chung | Internal Medicine | Flushing, NY | 1,155 | $651K |
| 13 | Yunkyoung Jeong | Nurse Practitioner | Woodside, NY | 821 | $592K |
| 14 | Guozi Weng | Nurse Practitioner | New York, NY | 753 | $548K |
| 15 | Weining Liang | Internal Medicine | Flushing, NY | 666 | $481K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 252 | Eslicarbazepine Acetate (Aptiom) | $51.1M | 31,472 |
| 253 | Risdiplam (Evrysdi) | $51.1M | 1,891 |
| 254 | Amikacin Liposomal/Neb.Accessr (Arikayce) | $50.5M | 3,394 |
| 255 | Diclofenac Epolamine (Licart) | $50.5M | 72,299 |
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology